CODX vs EW
Co-Diagnostics, Inc. Common Stock (CODX) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
CODX currently screens at market cap $31.4M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the CODX and EW stock pages for the full models.
Not investment advice.